RESMED INC
United States·USD
Congressional Trades
Whale Activity
- Increased0
- New0
- Held0
- Decreased0
- Closed0
- No prior filing1
| Filer | Shares | Value | Change |
|---|---|---|---|
| BRIGHT ROCK CAPITAL MANAGEMENT, LLC | 15.5K | $3.4M | — |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Recent Insider Transactions
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Farrell Michael J.Chairman and CEO · Director | Sale | −4,991 | $222.44 | $1.1M | Sep 8, 2026 | Form 4 ↗ |
| FARRELL PETER CDirector · Director | Sale | −970 | $234.73 | $228K | Sep 2, 2026 | Form 4 ↗ |
| Farrell Michael J.Chairman and CEO · Director | Sale | −4,991 | $205.69 | $1.0M | Aug 7, 2026 | Form 4 ↗ |
| FARRELL PETER CDirector · Director | Sale | −8,000 | $225.00 | $1.8M | Aug 5, 2026 | Form 4 ↗ |
| Farrell Michael J.Chairman and CEO · Director | Sale | −4,991 | $218.55 | $1.1M | Jul 7, 2026 | Form 4 ↗ |
| Farrell Michael J.Chairman and CEO · Director | Sale | −4,991 | $193.96 | $968K | Jun 8, 2026 | Form 4 ↗ |
| Farrell Michael J.Chairman and CEO · Director | Option exercise | +4,991 | $146.34 | $730K | Jun 8, 2026 | Form 4 ↗ |
| Rider Michael JGlobal General Counsel | Tax withholding | −269 | $190.57 | $51K | Jun 1, 2026 | Form 4 ↗ |
| Farrell Michael J.Chairman and CEO · Director | Sale | −4,991 | $207.82 | $1.0M | May 7, 2026 | Form 4 ↗ |
| Farrell Michael J.Chairman and CEO · Director | Option exercise | +4,991 | $146.34 | $730K | May 7, 2026 | Form 4 ↗ |
| Farrell Michael J.Chairman and CEO · Director | Sale | −4,991 | $225.50 | $1.1M | Apr 7, 2026 | Form 4 ↗ |
| Farrell Michael J.Chairman and CEO · Director | Option exercise | +4,991 | $146.34 | $730K | Apr 7, 2026 | Form 4 ↗ |
| Sandercock BrettChief Financial Officer | Sale | −1,000 | $224.31 | $224K | Apr 1, 2026 | Form 4 ↗ |
| FARRELL PETER CDirector | Sale | −2,000 | $225.00 | $450K | Apr 1, 2026 | Form 4 ↗ |
| Farrell Michael J.Chairman and CEO · Director | Sale | −4,991 | $251.03 | $1.3M | Mar 9, 2026 | Form 4 ↗ |
| Farrell Michael J.Chairman and CEO · Director | Option exercise | +4,991 | $146.34 | $730K | Mar 9, 2026 | Form 4 ↗ |
| FARRELL PETER CDirector | Sale | −2,000 | $260.22 | $520K | Mar 4, 2026 | Form 4 ↗ |
| Sandercock BrettChief Financial Officer | Sale | −1,000 | $254.30 | $254K | Mar 2, 2026 | Form 4 ↗ |
| Farrell Michael J.Chairman and CEO · Director | Sale | −4,991 | $273.78 | $1.4M | Feb 9, 2026 | Form 4 ↗ |
| Farrell Michael J.Chairman and CEO · Director | Option exercise | +4,991 | $146.34 | $730K | Feb 9, 2026 | Form 4 ↗ |
Fund Holders
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 4.6M | $897.5M | 0.04% | Jun 30, 2026 |
| VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS | 3.8M | $732.4M | 0.04% | Jun 30, 2026 |
| VANGUARD MID-CAP INDEX FUND VANGUARD INDEX FUNDS | 3.1M | $612.5M | 0.27% | Jun 30, 2026 |
| iShares Core S&P 500 ETF iShares Trust | 2.0M | $388.8M | 0.04% | Jun 30, 2026 |
| VANGUARD GROWTH INDEX FUND VANGUARD INDEX FUNDS | 1.9M | $363.6M | 0.10% | Jun 30, 2026 |
| Fidelity 500 Index Fund Fidelity Concord Street Trust | 1.9M | $355.3M | 0.04% | May 31, 2026 |
| State Street(R) SPDR(R) S&P 500(R) ETF Trust | 1.8M | $342.6M | 0.04% | Jun 30, 2026 |
| First Trust Rising Dividend Achievers ETF First Trust Exchange-Traded Fund VI | 1.4M | $272.1M | 1.11% | Jun 30, 2026 |
| VANGUARD MID-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 1.1M | $216.6M | 0.62% | Jun 30, 2026 |
| Invesco S&P 500 Equal Weight ETF Invesco Exchange-Traded Fund Trust | 963.5K | $203.3M | 0.21% | Jul 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list RMD's shares (CUSIP 761152107), each fund at its latest report since Mar 8, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
- AustralianSuper Pty LtdSCHEDULE 13G · passive (13G) · 8.3M shares5.7%
Aug 7, 2026 · ↗
Corporate Lobbying
This section is temporarily unavailable, reload in a minute.
Government Contracts
This section is temporarily unavailable, reload in a minute.
U.S. Patents
This section is temporarily unavailable, reload in a minute.
Annual Financials
No annual XBRL figures on record for RMD. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
This section is temporarily unavailable, reload in a minute.
Material Events (8-K)
- 8-K · Items 8.01Other eventsSep 1, 2026
EDGAR ↗ - 8-K · Items 4.01, 5.02, 7.01, 9.01Change in auditor · Officer / director change · Reg FD disclosureAug 17, 2026
EDGAR ↗ - 8-K · Items 2.02, 8.01, 9.01Results of operations · Other eventsAug 6, 2026
EDGAR ↗ - 8-K · Items 2.02, 7.01, 9.01Results of operations · Reg FD disclosureJul 7, 2026
EDGAR ↗
About RESMED INC
General We are a global leader in digital health and cloud-connected medical devices. We design innovative technology to empower people to live happier, healthier lives. Our artificial intelligence, or AI, powered digital health solutions, cloud-connected devices and intelligent software are designed to make home healthcare more personalized, accessible and effective. By enabling better care, our products improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems. Following our formation in 1989, we commercialized a continuous positive airway pressure, or CPAP, treatment for obstructive sleep apnea, or OSA, which was the first successf…